Probiotics & the COVID-19 market transformation – webinar

Now available on-demand.

September 16, 2020

1 Min Read

Watch Now-Green Button_ [Converted].png

As 2020 grappled with a global pandemic that has affected every aspect of society and business, the “now what?” is confronting us. The probiotic industry marched on, albeit in a transformative way. What were the lessons learned, takeaways and possible opportunities, and is this market ready for a potential second wave? The session will touch upon what happened, the effects and what transpired in the probiotics industry while we weren’t looking. We’ll cover:

  • Insights on the impact on ingredient and finished product sales

  • The science around probiotics for today’s health challenges: stress, digestive upset and more

  • What happened in the background around regulations and taxonomy

Session Chairs:

Heather Granato 117x132.jpg

Heather Granato, Vice President, Content, Health & Nutrition, Informa Markets

George Paraskevakos 117x132.jpg

George Paraskevakos, Executive Director, International Probiotics Association (IPA)


Jeremy Bartos, Ph.D., senior vice president, research and development, MeriCal
Ewa Hudson, director of insights, Lumina Intelligence
David Keller, DPM, MBA, owner, Keller Consulting Group
Dr. Vicente Navarro, CEO, Bioithas
Matthew Oster, head of consumer health, Euromonitor International
Flavia Prodam, M.D., Ph.D., associate professor in nutrition, Department of Health Sciences, University of Eastern Piedmont, Italy
Thomas Tompkins, Ph.D., research director, Rosell Institute from Microbiome and Probiotics within Lallemand Health Solutions Inc.
Ivan Wasserman, managing partner, Amin Talati Wasserman LLP

Produced with the support of:


Underwritten by:

Probiotics webinar logo block.jpg

Watch Now-Green Button_ [Converted].png

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like